The table below shows Moderna, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$389.00M
$1.02B
$142.00M
$108.00M
$1.86B
$241.00M
Cost of revenue
$955.00M
$207.00M
$119.00M
$90.00M
$514.00M
$115.00M
Gross profit
-
-
-
-
-
-
R&D
$649.00M
$801.00M
$700.00M
$856.00M
$1.14B
$1.22B
MRNA annual revenue (10-K history)
Moderna, Inc. reported annual revenue of $1.94B for fiscal year 2025. That is down 39.9% from $3.24B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $108.40M (FY 2016) to $1.94B. Figures come from the company's audited annual reports as filed with the SEC.
